-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shi Si Pharmaceutical Obtains Another Invention Patent
Category:
Time：2020-03-21
Recently, the research achievement “A Sofosbuvir Tablet and Its Preparation Method,” independently developed by Shijiazhuang No.4 Pharmaceutical Co., Ltd., has been granted authorization by the National Intellectual Property Administration.
Recently, the research achievement “A Sofosbuvir Tablet and Its Preparation Method,” independently developed by Shijiazhuang Sihua Pharmaceutical Co., Ltd., has been granted authorization by the National Intellectual Property Administration.
This invention provides a sofosbuvir tablet and a method for its preparation. Compared with the existing technologies, it significantly improves the dissolution rate of sofosbuvir formulations, enhances production efficiency, reduces manufacturing costs, and is well-suited for large-scale industrial production.
Technological innovation is the cornerstone for enterprises to achieve high-quality development. In recent years, Shijiazhuang Fourth Pharmaceutical has continuously increased its investment in scientific research, steadily upgraded its research and innovation platforms, and actively improved its related management systems, thereby boosting the innovative enthusiasm of its research teams. As a result, the number of patents held by the company has been steadily rising. To date, the company has been granted a total of 79 patents, including 47 invention patents and 27 utility model patents. These intellectual property achievements provide strong technological support for optimizing products, expanding markets, and enhancing the company’s core competitiveness.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license